At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 150 enrolled
Drug / intervention
Iron Supplement +1 moredrug
Likely dose
Iron Supplement 2 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Trial Comparing Iron Supplementation Versus Routine Iron Intake in Very Low Birth Weight (VLBW) Infants
The University of Texas Health Science Center, Houston·interventional·Posted Oct 19, 2010·Updated Jun 19, 2015
In Brief
A Phase 3 clinical trial evaluating Iron Supplement and control for Anemia. Completed, enrolled 150 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if iron supplementation in addition to routine iron intake decreases the risk of developing anemia in preterm infants.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2010
First PostedOct 2010
Primary CompletionFeb 2012
TodayJul 2026
First PostedOct 19, 2010
Enrollment StartJul 1, 2010
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 15.7 years ago
Interventions
Iron Supplementdrug
2 mg/kg/day elemental iron as multivitamin with iron solution
controldrug
multivitamin solution without iron